Data / Research funding / Stem Cell Research
Stem Cell Research: 4,596 NIH awards ($4B) to 489 organizations
4,596 NIH awards ($4B) in the NIH spending category Stem Cell Research, to 489 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 4,596 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders | NIH | National Institute of Mental Health | 2021 to 2024 | $39,202,732 | July 1, 2003 | February 28, 2026 | KNOWLES, JAMES A | reporter.nih.gov |
| Idaho INBRE Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,939,274 | September 30, 2001 | August 31, 2030 | BOHACH, CAROLYN HOVDE | reporter.nih.gov |
| UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $21,851,455 | September 1, 2025 | August 31, 2026 | SCHULICK, RICHARD D | reporter.nih.gov |
| Nebraska Research Network in Functional Genomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,833,603 | September 30, 2001 | April 30, 2026 | SORGEN, PAUL L | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,528,719 | June 1, 1997 | June 30, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Baylor College of Medicine Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,034,443 | July 1, 2007 | June 30, 2030 | REDDY, PAVAN | reporter.nih.gov |
| CWRU Center for Excellence on the Impact of Substance Use on HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $16,213,687 | September 15, 2021 | May 31, 2027 | LEVINE, ALAN DAVID | reporter.nih.gov |
| The Alzheimer's Disease Research Center at the University of California, Irvine | NIH | National Institute on Aging | 2021 to 2025 | $16,032,156 | June 15, 2020 | March 31, 2030 | LAFERLA, FRANK M | reporter.nih.gov |
| The University of Kansas Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $13,943,269 | July 11, 2012 | June 30, 2027 | JENSEN, ROY A. | reporter.nih.gov |
| Kynurenine accumulation drives loss of muscle and bone function with aging | NIH | National Institute on Aging | 2021 to 2025 | $11,563,609 | May 1, 2011 | May 31, 2027 | ISALES, CARLOS M. | reporter.nih.gov |
| COBRE in Human Genetics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $10,847,075 | February 10, 2021 | January 31, 2027 | MACKAY, TRUDY F. | reporter.nih.gov |
| Molecular Vector and Conditional ES Cell Clone Collection Validation and Maintenance Plan by theMMRRC at UC Davis | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $10,759,343 | August 1, 2025 | January 31, 2026 | LLOYD, KC KENT | reporter.nih.gov |
| Center for 3D Structure and Physics of the Genome | NIH | National Human Genome Research Institute | 2021 to 2024 | $9,564,360 | September 18, 2020 | June 30, 2026 | DEKKER, JOB | reporter.nih.gov |
| Inherited T cell defects: Diagnosis, Mechanisms and Treatments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,040,281 | September 8, 2020 | August 31, 2025 | MARSON, ALEXANDER | reporter.nih.gov |
| Therapeutic gene editing and multimodal imaging in juvenile macular degeneration | NIH | National Eye Institute | 2021 to 2024 | $8,710,741 | June 1, 2020 | May 31, 2026 | TSANG, STEPHEN H | reporter.nih.gov |
| Multiscale Analyses of 4D Nucleome Structure and Function by Comprehensive Multimodal Data Integration | NIH | National Human Genome Research Institute | 2021 to 2024 | $8,301,636 | September 22, 2020 | June 30, 2026 | MA, JIAN | reporter.nih.gov |
| Center of Biomedical Research Excellence in Matrix Biology Phase II | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $8,248,947 | August 1, 2014 | May 31, 2025 | OXFORD, JULIA THOM | reporter.nih.gov |
| Rat Resource and Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $7,587,318 | June 1, 2001 | April 30, 2026 | BRYDA, ELIZABETH C | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| IGF::OT::IGFEMMES NEIS-V | NIH | Office of the Director, National Institutes of Health | 2021 | $7,315,897 | November 1, 2016 | October 31, 2021 | HAMMEL, KERI | reporter.nih.gov |
| Exosomes as mediators of cardiac injury and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,022,243 | September 1, 2017 | June 30, 2029 | KISHORE, RAJ | reporter.nih.gov |
| Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,998,766 | August 20, 2020 | June 30, 2025 | SEALE, PATRICK | reporter.nih.gov |
| FMRP-mediated Regulation in Human Brain Development and Therapeutic Advancement | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $6,546,370 | September 25, 2020 | June 30, 2025 | JIN, PENG | reporter.nih.gov |
| From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $6,459,020 | May 15, 2019 | April 30, 2025 | BERNSTEIN, DANIEL | reporter.nih.gov |
| Molecular Circuits in the Hematopoietic Stem Cell Niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,422,507 | August 15, 2020 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Metals and Metal Mixtures: Cognitive Aging, Remediation and Exposure Sources (MEMCARE) | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $6,396,550 | February 21, 2020 | May 9, 2025 | LU, QUAN | reporter.nih.gov |
| Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $6,353,055 | May 15, 2020 | April 30, 2026 | TSAI, LI-HUEI | reporter.nih.gov |
| The second phase of NIH Common Fund 4D Nucleome Network Organizational Hub | NIH | National Cancer Institute | 2021 to 2024 | $6,160,327 | March 1, 2024 | August 31, 2024 | ZHONG, SHENG | reporter.nih.gov |
| Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $5,901,662 | August 15, 2020 | May 31, 2026 | POLLAK, MARTIN R. | reporter.nih.gov |
| A regulome and transcriptome atlas of fetal and adult human neurogenesis | NIH | National Institute of Mental Health | 2021 | $5,548,451 | September 20, 2021 | September 19, 2025 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Regulation of cellular pathways in human brain development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,467,336 | July 1, 2014 | May 31, 2025 | ALVAREZ-BUYLLA, ARTURO | reporter.nih.gov |
| Actin assembly and clathrin-mediated endocytosis in yeast and mammals | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,442,792 | July 1, 2016 | June 30, 2026 | DRUBIN, DAVID G | reporter.nih.gov |
| Center for Integrated Multi-modal and Multi-scale Nucleome Research | NIH | National Human Genome Research Institute | 2021 to 2024 | $5,406,000 | September 24, 2020 | June 30, 2025 | REN, BING | reporter.nih.gov |
| A Human iPSC-based Cell Therapy for Canavan Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,276,950 | June 15, 2021 | May 31, 2027 | SHI, YANHONG | reporter.nih.gov |
| The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression | NIH | National Cancer Institute | 2023 to 2025 | $5,126,849 | September 22, 2022 | August 31, 2027 | CHAN, KEITH SYSON | reporter.nih.gov |
| Trisomy 21 and its impact on hedgehog-dependent gene regulation and differentiation timing | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $5,112,898 | September 1, 2024 | March 31, 2026 | MOSKOWITZ, IVAN PAUL | reporter.nih.gov |
| IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease. | NIH | National Institute on Aging | 2021 to 2023 | $4,958,940 | May 1, 2020 | April 30, 2026 | RODGERS, KATHLEEN E. | reporter.nih.gov |
| A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,780,411 | April 5, 2019 | March 31, 2026 | WILCOX, DAVID ALLEN | reporter.nih.gov |
| Placental models to support embryogenesis in vitro | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $4,662,000 | September 30, 2020 | July 31, 2026 | ZERNICKA-GOETZ, MAGDALENA | reporter.nih.gov |
| Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,582,323 | September 20, 2018 | July 31, 2024 | STAHL, ANDREAS | reporter.nih.gov |
| Dynamics of chromosome organization and chromatin states in single cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,544,908 | September 19, 2020 | June 30, 2025 | CAI, LONG | reporter.nih.gov |
| Illuminating Function of the Understudied Druggable Kinome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,503,990 | September 15, 2017 | December 31, 2024 | JOHNSON, GARY L. | reporter.nih.gov |
| Early Pathogenesis of Cystic Fibrosis Related Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,452,977 | April 30, 2021 | March 31, 2024 | ENGELHARDT, JOHN F | reporter.nih.gov |
| Progenitor Regulation in Craniofacial Development and Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $4,376,497 | September 14, 2017 | June 30, 2026 | CRUMP, GAGE D | reporter.nih.gov |
| UAB Childhood Cystic Kidney Disease Center (UAB-CCKDC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,330,298 | July 20, 2020 | August 31, 2030 | YODER, BRADLEY K. | reporter.nih.gov |
| Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,324,679 | September 20, 2018 | July 31, 2023 | TAYLOR, D. LANSING | reporter.nih.gov |
| Live-cell multiplex super-resolution imaging of chromatin state transitions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,225,012 | September 15, 2020 | June 30, 2026 | BINTU, LACRAMIOARA | reporter.nih.gov |
| Development and Expansion of the Human Cerebral Cortex | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,211,732 | December 1, 2016 | November 30, 2024 | KRIEGSTEIN, ARNOLD | reporter.nih.gov |
| A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,203,696 | August 15, 2020 | May 31, 2025 | GRIMES, H. LEIGHTON | reporter.nih.gov |
| Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis | NIH | National Institute on Aging | 2021 to 2024 | $4,178,124 | September 30, 2021 | May 2, 2025 | ADORNO, MADDALENA | reporter.nih.gov |
| Genome-Wide Discovery and Translational Research for Neural Repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,147,990 | December 1, 2016 | November 30, 2025 | STRITTMATTER, STEPHEN M | reporter.nih.gov |
| Generation of Novel Genetic Tools to Study Cellular Heterogeneity in Adipose Tissues | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,098,938 | July 17, 2019 | October 31, 2024 | SCHERER, PHILIPP E | reporter.nih.gov |
| Genetic neuroscience: How human genes and alleles shape neuronal phenotypes | NIH | National Institute of Mental Health | 2021 | $4,026,586 | September 20, 2017 | July 31, 2023 | MCCARROLL, STEVEN ANDREW | reporter.nih.gov |
| BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD)- TASK A. CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,969,819 | September 1, 2020 | August 31, 2025 | WU, JOSEPH | reporter.nih.gov |
| Cardiac lineage determination and nuclear architecture | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,927,168 | January 1, 2018 | December 31, 2024 | EPSTEIN, JONATHAN A. | reporter.nih.gov |
| Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,926,545 | March 1, 2018 | February 28, 2026 | NEWMAN, PETER J | reporter.nih.gov |
| Imaging organ system interfaces in ischemic heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,920,729 | February 1, 2018 | January 31, 2025 | NAHRENDORF, MATTHIAS | reporter.nih.gov |
| Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue | NIH | National Institute on Aging | 2021 to 2024 | $3,903,556 | May 1, 2020 | April 30, 2026 | TESCO, GIUSEPPINA | reporter.nih.gov |
| Perturbing the LXR/SREBP axis to decipher protective and pathogenic AD/ADRD microglial phenotypes | NIH | National Institute on Aging | 2024 | $3,840,870 | May 1, 2024 | April 30, 2027 | GLASS, CHRISTOPHER K | reporter.nih.gov |
| BMT Survivor Study-2 (BMTSS-2) | NIH | National Cancer Institute | 2021 to 2023 | $3,811,745 | April 1, 2019 | March 31, 2025 | BHATIA, SMITA | reporter.nih.gov |
| A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy | NIH | National Eye Institute | 2021 to 2024 | $3,781,701 | September 30, 2021 | July 31, 2026 | FU, YINGBIN | reporter.nih.gov |
| Elucidating the Biological Differences Between Distinct Fibrillar and Non-Fibrillar Alpha-Synuclein Inclusions in Human Stem-Cell Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,706,946 | July 1, 2020 | April 30, 2026 | KHURANA, VIKRAM | reporter.nih.gov |
| Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,695,974 | May 1, 2021 | October 31, 2024 | CAIN, MATTHEW D | reporter.nih.gov |
| Molecular recording to predict cell fate decisions and animal behavior | NIH | National Institute of Mental Health | 2021 | $3,693,282 | August 1, 2021 | July 31, 2025 | MITRA, ROBI D | reporter.nih.gov |
| Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,682,052 | February 1, 2021 | January 31, 2025 | CHI, NEIL C | reporter.nih.gov |
| Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort | NIH | National Institute of Mental Health | 2022 to 2024 | $3,678,769 | August 1, 2022 | May 31, 2027 | MULLE, JENNIFER GLADYS | reporter.nih.gov |
| 1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,521,212 | September 15, 2020 | August 31, 2025 | BERGER, STUART | reporter.nih.gov |
| Construction of an Integrated Immune - Vascular Brain - Chip as a Platform for the Study, Drug Screening, and Treatments of Alzheimer's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $3,475,569 | September 20, 2019 | May 31, 2024 | TSAI, LI-HUEI | reporter.nih.gov |
| Development of a Clinical Hemoglobin Modulator | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,473,811 | June 1, 2020 | May 31, 2024 | PERRINE, SUSAN PARK | reporter.nih.gov |
| Immunobiology of Lung Injury and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,455,443 | January 21, 2019 | December 31, 2024 | MOORE, BETHANY B. | reporter.nih.gov |
| The MYC Transcription Factor Network and the Path to Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,449,610 | September 1, 2018 | August 31, 2025 | EISENMAN, ROBERT NEIL | reporter.nih.gov |
| Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopment | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,437,163 | December 1, 2016 | November 30, 2024 | MING, GUO-LI | reporter.nih.gov |
| Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,398,319 | January 15, 2019 | December 31, 2024 | LEEPER, NICHOLAS JAMES | reporter.nih.gov |
| Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $3,386,194 | September 15, 2020 | May 31, 2026 | ZHANG, BIN | reporter.nih.gov |
| Microphysiological systems for modeling autoimmunity in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,372,768 | August 2, 2019 | July 31, 2025 | STANGER, BEN Z | reporter.nih.gov |
| Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,366,623 | June 1, 2014 | August 10, 2024 | WEINBERGER, LEOR S | reporter.nih.gov |
| Genetic Control of Cardiac Development: Congenital Heart Disease Gene Discovery in Drosophila | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,338,929 | August 1, 1995 | June 30, 2025 | BODMER, ROLF | reporter.nih.gov |
| Vascular smooth muscle cell heterogeneity and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,305,617 | March 1, 2021 | December 31, 2025 | SIMONS, MICHAEL | reporter.nih.gov |
| Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,303,112 | September 15, 2020 | June 30, 2025 | SUH, YOUSIN | reporter.nih.gov |
| Identification of the active nuclear niche(s) using novel proteomic, genomic, transgenic, and live-cell microscopy technologies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,283,997 | September 15, 2020 | June 30, 2026 | BELMONT, ANDREW STEVEN | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Optic Neuropathies | NIH | National Eye Institute | 2021 to 2024 | $3,242,042 | September 30, 2018 | August 31, 2024 | GOLDBERG, JEFFREY L | reporter.nih.gov |
| Genetically Diverse Mouse Embryonic Stem Cells: A Platform for Cellular Systems Genetics | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $3,241,681 | March 1, 2021 | May 31, 2025 | REINHOLDT, LAURA G | reporter.nih.gov |
| Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,218,917 | August 15, 2015 | June 30, 2026 | JENQ, ROBERT | reporter.nih.gov |
| Cell specific delivery of novel therapies to enhance glomerular regeneration and repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,199,320 | September 1, 2020 | May 31, 2025 | SHANKLAND, STUART JAMES | reporter.nih.gov |
| Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | NIH | National Cancer Institute | 2021 to 2024 | $3,192,137 | April 1, 2020 | March 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Isolation, characterization and translational development of glioma stem cells | NIH | National Cancer Institute | 2021 to 2023 | $3,189,696 | February 1, 2017 | January 31, 2025 | PARADA, LUIS FERNANDO | reporter.nih.gov |
| Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV | NIH | National Institute on Aging | 2021 to 2024 | $3,183,836 | May 1, 2020 | February 28, 2026 | MA, QING | reporter.nih.gov |
| Next Generation Therapies for Fertility Preservation in Male Cancer Patients | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,165,939 | May 15, 2020 | April 30, 2025 | ORWIG, KYLE EDWIN | reporter.nih.gov |
| Ex Vivo Generation of Functional Kidney Tissues for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,161,308 | September 1, 2020 | May 14, 2025 | LEWIS, JENNIFER A. | reporter.nih.gov |
| Modeling intestinal dysfunction in HIV infection with organoid technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,127,465 | January 10, 2020 | December 31, 2025 | OTT, MELANIE MARIA | reporter.nih.gov |
| Modeling diabetes using an integrated plate system | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,092,998 | September 20, 2018 | July 31, 2024 | WELLS, JAMES M | reporter.nih.gov |
| Multimodal Analysis of Gestational Health and Placental Injury in Opioid-Affected Pregnancies | NIH | National Institute on Drug Abuse | 2023 | $3,092,159 | August 15, 2023 | July 30, 2026 | OUYANG, YINGSHI | reporter.nih.gov |
| ENCODE Mapping Center-A Comprehensive Catalog of DNase I Hypersensitive Sites | NIH | National Human Genome Research Institute | 2021 | $3,086,945 | February 1, 2021 | January 31, 2023 | STAMATOYANNOPOULOS, JOHN A | reporter.nih.gov |
| Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,081,124 | January 16, 2020 | December 31, 2024 | YANG, OTTO O | reporter.nih.gov |
| Harnessing natural stem cell-based strategies for mammalian dental renewal | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $3,080,448 | September 22, 2016 | June 30, 2024 | KLEIN, OPHIR D | reporter.nih.gov |
| Genetic determinants of 4D genome folding in human cardiac development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,069,960 | September 21, 2020 | August 31, 2025 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Promoting Brain Resilience to Alzheimer's Neuropathology | NIH | National Institute on Aging | 2021 to 2024 | $3,062,659 | August 1, 2020 | April 30, 2026 | TAGLIALATELA, GIULIO | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $3,026,491 | September 30, 2018 | August 31, 2024 | REX, TONIA S | reporter.nih.gov |
| Investigating the role of adipose tissue in mobility and aging (SOMMA-AT) | NIH | National Institute on Aging | 2021 to 2024 | $3,021,652 | September 15, 2020 | May 31, 2025 | SPARKS, LAUREN MARIE | reporter.nih.gov |
| Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models | NIH | National Institute on Aging | 2021 to 2024 | $3,018,880 | August 15, 2020 | April 30, 2026 | WEN, ZHEXING | reporter.nih.gov |
| A 3D vascularized islet biomimetic to model type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,017,660 | August 1, 2019 | January 31, 2025 | SANDER, MAIKE | reporter.nih.gov |
| Therapeutic Implications of Molecular Defects in Bone Marrow Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,016,565 | January 12, 2017 | December 31, 2023 | MACIEJEWSKI, JAROSLAW P. | reporter.nih.gov |
| Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy | NIH | National Cancer Institute | 2021 to 2023 | $3,015,518 | September 21, 2017 | August 31, 2024 | WEISSMAN, IRVING L. | reporter.nih.gov |
| Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $3,003,024 | August 1, 2018 | July 31, 2024 | WIKSWO, JOHN PETER | reporter.nih.gov |
| BRITE-Eye: An integrated discovery engine for CNS therapeutic targets driven by high throughput genetic screens, functional readouts in human neurons, and machine learning | NIH | National Institute of Mental Health | 2023 to 2024 | $2,999,997 | September 19, 2023 | August 31, 2025 | WILLIAMS, LUIS ALBERTO | reporter.nih.gov |
| Impact of peripheral nerves on mesenchymal cell fate in extremity trauma | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,991,689 | August 1, 2017 | April 30, 2026 | LEVI, BENJAMIN | reporter.nih.gov |
| Defining Genetic Architecture and Pathways of DCM | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,976,096 | April 1, 2005 | January 31, 2026 | SEIDMAN, JONATHAN G | reporter.nih.gov |
| TREM2-mediated microglial dynamic function in Alzheimer disease | NIH | National Institute on Aging | 2021 to 2024 | $2,968,448 | February 1, 2020 | December 31, 2025 | ZHAO, NA | reporter.nih.gov |
| MIDAS: MIcroangiopathy, endothelial Damage in Adults undergoing Stem cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,957,506 | August 20, 2020 | July 31, 2026 | VASU, SUMITHIRA | reporter.nih.gov |
| Defining disease mechanisms in SLC35A2 epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,951,492 | July 1, 2020 | April 30, 2025 | HEINZEN, ERIN L | reporter.nih.gov |
| Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,950,878 | December 1, 2016 | November 30, 2024 | GUTMANN, DAVID H | reporter.nih.gov |
| Extremely high-throughput mapping of protein, RNA, and chromatin interactions in health and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,945,203 | July 30, 2020 | June 30, 2025 | ZHONG, SHENG | reporter.nih.gov |
| Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome | NIH | National Institute on Aging | 2021 to 2024 | $2,943,744 | April 15, 2020 | March 31, 2026 | FINKBEINER, STEVEN M | reporter.nih.gov |
| Polyunsaturated fatty acids as anti-arrhythmic agents. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,942,029 | September 15, 2016 | March 31, 2026 | BARRO-SORIA, RENE | reporter.nih.gov |
| Mechanistic Basis of Cardiac Laminopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,934,243 | September 16, 2021 | June 30, 2026 | WORMAN, HOWARD J | reporter.nih.gov |
| Identifying Alzheimer’s Disease Causal Variants and Target Genes Using iPSC-derived Microglia | NIH | National Institute on Aging | 2021 to 2024 | $2,922,756 | April 15, 2020 | March 31, 2025 | PHANSTIEL, DOUGLAS H. | reporter.nih.gov |
| Origin and Function of Intra-epithelial Mast Cells in Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,919,325 | April 1, 2021 | March 31, 2026 | HALLSTRAND, TEAL S | reporter.nih.gov |
| Induced neuronal cells: A novel tool to study neuropsychiatric diseases | NIH | National Institute of Mental Health | 2021 to 2024 | $2,918,957 | September 29, 2010 | August 31, 2025 | WERNIG, MARIUS | reporter.nih.gov |
| Systematic Reconstruction of Epithelial-Mesenchymal Communication in Organ Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,918,081 | August 15, 2021 | July 31, 2026 | LI, PULIN | reporter.nih.gov |
| Dissecting the role of NOTCH2NL genes in human brain development and neurological disorders associated with chromosome 1q21.1 distal duplications and deletions. | NIH | National Institute of Mental Health | 2021 to 2024 | $2,907,904 | April 15, 2020 | January 31, 2026 | SALAMA, SOFIE REDA | reporter.nih.gov |
| Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sample | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $2,906,922 | November 11, 2020 | July 31, 2023 | AL-HENDY, AYMAN | reporter.nih.gov |
| Extracellular Vesicle treatment and age-related neuropathology in non-human primates | NIH | National Institute on Aging | 2021 to 2024 | $2,902,850 | September 15, 2020 | April 30, 2026 | MOORE, TARA L | reporter.nih.gov |
| Retinal disease models for translational photoreceptor replacement | NIH | National Eye Institute | 2021 to 2022 | $2,898,123 | September 30, 2018 | May 31, 2025 | WOLFE, JOHN H | reporter.nih.gov |
| Study the Protective Roles of ApoE2 in Alzheimer's Disease Using Reprogrammed Isogenic Cells | NIH | National Institute on Aging | 2021 to 2024 | $2,897,144 | May 1, 2020 | March 31, 2025 | HUANG, YADONG | reporter.nih.gov |
| Higher Precision Human and Mouse Transcriptomes | NIH | National Human Genome Research Institute | 2021 | $2,888,702 | February 1, 2017 | January 31, 2023 | WOLD, BARBARA J | reporter.nih.gov |
| Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative disease | NIH | National Institute of Mental Health | 2023 to 2024 | $2,885,988 | September 15, 2023 | August 31, 2025 | SACHS, KAREN | reporter.nih.gov |
| The Pathogenesis of RNA Splicing Factor Associated Retinal Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,874,308 | April 1, 2011 | March 31, 2026 | PIERCE, ERIC A | reporter.nih.gov |
| Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,867,908 | June 1, 2020 | May 31, 2026 | WALLER, EDMUND K | reporter.nih.gov |
| Translational assessment of brain bioenergetic function in schizophrenia | NIH | National Institute of Mental Health | 2021 to 2024 | $2,863,277 | December 1, 2019 | October 31, 2025 | MARANO, CHRISTOPHER | reporter.nih.gov |
| Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,861,646 | January 1, 2017 | December 31, 2024 | GINSBERG, HENRY N | reporter.nih.gov |
| Single Cell Transciptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,859,989 | September 1, 2022 | August 31, 2025 | CHENG, CHRISTINE | reporter.nih.gov |
| DROSOPHILA GENOMICS RESOURCE CENTER | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $2,858,854 | April 1, 2002 | March 31, 2029 | ZELHOF, ANDREW | reporter.nih.gov |
| Quantitative Multiparametric MRI to Assess the Effect of Stem Cell Therapy on Chronic Low Back Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,858,064 | August 1, 2014 | July 31, 2025 | LI, DEBIAO | reporter.nih.gov |
| Molecular regulation of native hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,856,222 | February 15, 2016 | December 31, 2025 | CAMARGO, FERNANDO | reporter.nih.gov |
| Function of Neurexins | NIH | National Institute of Mental Health | 2021 to 2024 | $2,855,805 | September 30, 1994 | February 28, 2025 | SUDHOF, THOMAS C. | reporter.nih.gov |
| Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,855,157 | May 1, 2020 | April 30, 2026 | KELLER, MICHAEL DANIEL | reporter.nih.gov |
| Wnt signaling in hematopoietic development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,849,578 | January 1, 2017 | June 30, 2025 | WILLERT, KARL H | reporter.nih.gov |
| Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,844,000 | August 15, 2021 | June 30, 2025 | BOROK, ZEA | reporter.nih.gov |
| HEMANGIOBLAST DEVELOPMENT AND REGULATION | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,843,107 | August 1, 1996 | May 31, 2026 | CHOI, KYUNGHEE | reporter.nih.gov |
| JAK-STAT Control of Zika Virus-Induced Fetal Injury | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,840,817 | July 1, 2019 | June 30, 2025 | ADAMS WALDORF, KRISTINA M. | reporter.nih.gov |
| Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research | NIH | National Eye Institute | 2021 to 2022 | $2,820,106 | September 30, 2018 | August 31, 2022 | CARROLL, JOSEPH | reporter.nih.gov |
| Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis | NIH | National Institute on Aging | 2022 | $2,818,493 | August 1, 2022 | July 31, 2025 | HUANG, TIMOTHY YIKAI | reporter.nih.gov |
| Mechanisms of HIV-associated epithelialintestinal stem cell (ISC) dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,811,833 | July 1, 2020 | June 30, 2025 | KWON, DOUGLAS | reporter.nih.gov |
| Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,799,613 | May 1, 2020 | February 28, 2026 | HUSSAIN, SALIK | reporter.nih.gov |
| Discovery of diabetes-relevant ò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,792,424 | September 15, 2020 | June 30, 2025 | HUANGFU, DANWEI | reporter.nih.gov |
| Polymer Scaffolds for Mandibular Condyle Cartilage Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,788,930 | December 1, 2020 | November 30, 2025 | ALMARZA, ALEJANDRO JOSE | reporter.nih.gov |
| Elastic, Degradable Vascular Grafts with Helical Microfibers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,787,042 | August 15, 2021 | July 31, 2025 | WANG, YADONG | reporter.nih.gov |
| Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,785,889 | February 1, 2020 | January 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Bioactive Scaffold for TMJ Disc Regeneration by Endogenous Stem/Progenitor Cells | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,782,994 | August 11, 2020 | July 31, 2026 | LEE, CHANG HUN | reporter.nih.gov |
| Intraosseous delivery of lentiviral vectors for hemophilia A gene therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,777,901 | August 15, 2016 | June 30, 2026 | MIAO, CAROL H | reporter.nih.gov |
| Genotype-guided therapy for atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,771,945 | July 15, 2020 | June 30, 2026 | DARBAR, DAWOOD | reporter.nih.gov |
| Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,764,144 | June 1, 2021 | July 31, 2025 | PRICE, JEFFREY H. | reporter.nih.gov |
| Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patients’ induced pluripotent stem cells and genome editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,760,413 | May 1, 2020 | April 30, 2026 | YANG, BO | reporter.nih.gov |
| Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma | NIH | National Cancer Institute | 2022 to 2024 | $2,754,572 | September 15, 2022 | August 31, 2027 | MCKEON, FRANK D. | reporter.nih.gov |
| Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes | NIH | National Cancer Institute | 2021 to 2024 | $2,742,067 | April 1, 2020 | March 31, 2025 | PARK, CHRISTOPHER Y | reporter.nih.gov |
| Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $2,741,939 | September 5, 2023 | August 31, 2025 | AHMED, SYED MUKHTAR | reporter.nih.gov |
| Sex-specific Molecular Profiling to Understand Pathology and Identify Causal Genes and Drug Targets for Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $2,740,705 | September 30, 2021 | August 31, 2024 | SUNG, YUNJU | reporter.nih.gov |
| Development of FAST-DOSE assay system for the rapid assessment of acute radiation exposure, individual radiosensitivity and injury in victims for a large-scale radiological incident | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,738,709 | February 1, 2020 | January 31, 2026 | TURNER, HELEN C | reporter.nih.gov |
| Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,732,942 | July 15, 2020 | April 30, 2026 | GUMMULURU, SURYARAM | reporter.nih.gov |
| Conformal Total Body and Marrow Irradiation for Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,727,228 | September 13, 2011 | December 31, 2025 | HUI, SUSANTA K | reporter.nih.gov |
| Charting the 3D epigenome in human brain development and diseases | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,724,871 | September 30, 2020 | August 31, 2025 | SHEN, YIN | reporter.nih.gov |
| Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,708,550 | July 15, 2021 | June 30, 2025 | HEROLD, KEVAN C | reporter.nih.gov |
| Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,694,538 | January 13, 2020 | December 31, 2025 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| Enhancing Innate Immune Reconstitution Post Allogeneic HSCT. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,685,463 | September 1, 2021 | June 30, 2025 | SERODY, JONATHAN S. | reporter.nih.gov |
| 1/7 Collaborative Genomic Studies of Tourette Disorder. | NIH | National Institute of Mental Health | 2021 to 2023 | $2,683,588 | June 15, 2018 | March 31, 2025 | HEIMAN, GARY A. | reporter.nih.gov |
| In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,680,549 | June 8, 2022 | April 1, 2025 | ADAIR, JENNIFER EILEEN | reporter.nih.gov |
| Transcriptional condensates, epigenetic editing and Rett Syndrome | NIH | National Institute of Mental Health | 2021 to 2023 | $2,677,396 | September 15, 2014 | July 31, 2025 | JAENISCH, RUDOLF | reporter.nih.gov |
| Metabolic Control of Stemness in lung epithelial progenitors by FAM13A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,676,003 | April 1, 2015 | November 30, 2025 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| How the 3D Architecture of the Brain Shapes Cancer Cell Fate Decisions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,670,000 | September 30, 2021 | August 31, 2026 | FILBIN, MARIELLA GRUBER | reporter.nih.gov |
| Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,663,582 | February 15, 2021 | January 31, 2026 | BLAZAR, BRUCE R | reporter.nih.gov |
| Transcriptional Control During Erythropoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,660,464 | September 16, 2013 | October 31, 2025 | RANISH, JEFFREY A | reporter.nih.gov |
| Molecular pathobiology of soluble TREM2 in Alzheimer's disease | NIH | National Institute on Aging | 2023 | $2,655,773 | April 1, 2017 | August 31, 2026 | HUANG, TIMOTHY YIKAI | reporter.nih.gov |
| Genomics of bone and body composition traits in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,651,635 | August 7, 2020 | June 30, 2026 | ZEMEL, BABETTE S | reporter.nih.gov |
| Modulating intrinsic beta cell stress to block diabetes pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,648,788 | August 15, 2021 | June 30, 2025 | PAPA, FEROZ R | reporter.nih.gov |
| Neuronal cell-cycle re-entry and neurodegeneration | NIH | National Institute on Aging | 2021 to 2024 | $2,635,489 | August 15, 2020 | May 31, 2025 | SOCKANATHAN, SHANTHINI | reporter.nih.gov |
| Regulation of Craniofacial Development by ALX Transcription Factors | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,632,904 | September 9, 2020 | August 31, 2025 | JIANG, RULANG | reporter.nih.gov |
| Comparative Genomics of Precursor Diversity and Function | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,631,720 | April 1, 2021 | February 28, 2026 | HAYDAR, TARIK F | reporter.nih.gov |
| Defining Characteristics of Cortical Progenitor Cells over Time in Mouse and Human | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,620,540 | December 15, 2016 | November 30, 2025 | TEMPLE, SALLY | reporter.nih.gov |
| An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,620,380 | September 15, 2021 | May 31, 2026 | GEORGE, STEVEN CARL | reporter.nih.gov |
| The role of the nucleolus in human genome organization in normal and disease states | NIH | National Cancer Institute | 2021 to 2024 | $2,619,610 | September 21, 2020 | August 31, 2025 | KAUFMAN, PAUL D. | reporter.nih.gov |
| Contributions of cell type and exosome signaling to prodromal synaptic and circuit changes in Alzheimer's Disease models | NIH | National Institute on Aging | 2022 | $2,618,631 | August 15, 2022 | July 31, 2025 | CLINE, HOLLIS T. | reporter.nih.gov |
| In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,618,613 | June 1, 2016 | July 31, 2025 | LIEBER, ANDRE MICHAEL | reporter.nih.gov |
| Synthetic gene sensors and effectors to redirect organoid development | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,608,452 | May 1, 2021 | July 31, 2025 | WEISS, RON | reporter.nih.gov |
| Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,608,434 | May 15, 2020 | April 30, 2026 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| REGULATION OF HEMATOPOIETIC PROGENITORS BY DE NOVO DNA METHYLATION | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,607,321 | July 1, 2011 | March 31, 2026 | GOODELL, MARGARET A. | reporter.nih.gov |
| Intravital analysis of hematopoietic stem cells in their bone marrow niche - Resubmission - 1 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,607,213 | September 20, 2021 | August 31, 2025 | REIZIS, BORIS | reporter.nih.gov |
| Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 | $2,601,749 | September 1, 2021 | August 31, 2024 | KELLY, JEFFERY W | reporter.nih.gov |
| NATIONAL BIOREPOSITORY OF LUNG DISEASE-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELLS:THE PURPOSE OF THIS RESOURCE IS TO BUILD AND SUPPORT A CRITICAL | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,600,000 | May 1, 2020 | April 30, 2025 | N/A, N/A | reporter.nih.gov |
| Probing the Cardiac PGC-1 Regulatory Cascade | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,593,540 | April 1, 1998 | March 31, 2025 | KELLY, DANIEL PATRICK | reporter.nih.gov |
| SINGLE-CELL CHEMICAL TRANSCRIPTOMIC DISSECTION OF AN ESSENTIAL TRANSCRIPTION FACTOR NETWORK | NIH | National Human Genome Research Institute | 2021 to 2024 | $2,587,499 | November 4, 2021 | August 31, 2026 | RAMANI, VIJAY | reporter.nih.gov |
| Synthetic organogenesis: new paradigms in reconstituting human organ development in vitro | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,586,456 | September 21, 2021 | August 31, 2026 | SIMUNOVIC, MIJO | reporter.nih.gov |
| Elucidating electrical stimulation induced non-neuronal activity using emerging in vivo imaging technology and electrophysiology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,585,973 | September 30, 2020 | June 30, 2025 | KOZAI, TAKASHI DANIEL YOSHIDA | reporter.nih.gov |
| Control of the 4D chromatin landscape underlying gene activity during development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,584,805 | September 17, 2020 | June 30, 2025 | GREGOR, THOMAS | reporter.nih.gov |
| Rectifying splicing mutations in blood disorders by gene editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,584,045 | December 20, 2019 | November 30, 2023 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Pediatric Heart Disease: Getting from Mutations to Therapeutics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,582,324 | February 15, 2017 | January 31, 2025 | GELB, BRUCE D | reporter.nih.gov |
| Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,577,835 | July 5, 2022 | June 30, 2027 | ADAIR, JENNIFER EILEEN | reporter.nih.gov |
| Identifying cell type-specific autonomous and non-autonomous interactions in AD | NIH | National Institute on Aging | 2022 | $2,567,371 | May 1, 2022 | April 30, 2025 | MENON, VILAS | reporter.nih.gov |
| The role of mTOR signaling in oligodendrocyte differentiation and CNS myelination | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,564,330 | September 30, 2012 | July 31, 2025 | MACKLIN, WENDY B | reporter.nih.gov |
| Neuronal excitability and copy number variation disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,563,265 | September 1, 2020 | May 31, 2026 | PENZES, PETER | reporter.nih.gov |
| The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,563,053 | August 1, 2020 | July 31, 2025 | HUARD, JOHNNY | reporter.nih.gov |
| Cellular models of fetal neurodevelopment in maternal SARS-CoV-2 infection | NIH | National Institute of Mental Health | 2022 | $2,560,905 | September 15, 2022 | September 14, 2025 | EDLOW, ANDREA GOLDBERG | reporter.nih.gov |
| Molecular Basis of Gene Regulation by Polycomb Repressive Complex 2 | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,560,793 | April 1, 2020 | March 31, 2026 | LIU, XIN | reporter.nih.gov |
| Activity-dependent Regulation of the Choroid Plexus-Cerebrospinal Fluid Stem Cell Niche | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,559,641 | May 15, 2014 | April 30, 2026 | LEHTINEN, MARIA | reporter.nih.gov |
| Biomarker discovery for parkinsonian diseases in extracellular vesicles from iPSC-derived neurons | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,555,369 | April 1, 2023 | March 31, 2026 | BITAN, GAL | reporter.nih.gov |
| Vascular networks genetically engineered for protein drug delivery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,552,882 | August 15, 2015 | April 30, 2026 | MELERO-MARTIN, JUAN M | reporter.nih.gov |
| Three-dimensional conformation changes associated with T cell memory and autoimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,550,277 | September 15, 2020 | June 30, 2025 | HAWKINS, RAYMOND DAVID | reporter.nih.gov |
| A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down Syndrome | NIH | National Institute on Aging | 2021 to 2024 | $2,549,299 | September 30, 2021 | August 31, 2026 | JIANG, PENG | reporter.nih.gov |
| Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,549,156 | September 30, 2020 | September 29, 2025 | STERN, JEFFREY H | reporter.nih.gov |
| Tissue chips for precision treatment of catecholaminergic polymorphic ventricular tachycardia | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,546,193 | September 1, 2020 | July 31, 2025 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,546,159 | February 7, 2020 | January 31, 2026 | SCHWOB, JAMES E. | reporter.nih.gov |
| Functional roles of lymphatics in organogenesis and tissue repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,543,362 | January 7, 2021 | December 31, 2025 | OLIVER, GUILLERMO C | reporter.nih.gov |
| 1/2 Cell Type and Region-Specific Regulatory Networks in Human Brain Development and Disorders | NIH | National Institute of Mental Health | 2021 to 2022 | $2,541,620 | July 6, 2018 | March 31, 2024 | SESTAN, NENAD | reporter.nih.gov |
| Cellular and Molecular Analysis of the Psychiatric Risk Gene Transcription Factor 4 (TCF4) | NIH | National Institute of Mental Health | 2021 to 2024 | $2,540,401 | September 2, 2016 | May 31, 2026 | MAHER, BRADY J | reporter.nih.gov |
| Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,537,267 | January 1, 2018 | November 30, 2025 | GAO, FEN-BIAO | reporter.nih.gov |
| Gaining insight into psychiatric disease by engineering piece by piece the human brain in vitro. | NIH | National Institute of Mental Health | 2021 to 2024 | $2,536,379 | August 1, 2015 | May 31, 2025 | PASCA, SERGIU | reporter.nih.gov |
| Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,535,698 | September 30, 2020 | June 30, 2026 | ALPERIN, MARIANNA | reporter.nih.gov |
| Methamphetamine Effect on HIV Persistence | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,535,677 | July 1, 2020 | May 31, 2025 | KAUL, MARCUS | reporter.nih.gov |
| Joint Program in Molecules, Cells, and Organisms | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,531,890 | July 1, 2020 | June 30, 2025 | D'SOUZA, VICTORIA MANUEL | reporter.nih.gov |
| Regulation of emergency hematopoiesis by the ubiquitin-proteasome system | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,530,317 | September 1, 2021 | May 31, 2025 | BUSINO, LUCA | reporter.nih.gov |
| Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,529,105 | August 24, 2017 | July 31, 2024 | WAYNE, ALAN S. | reporter.nih.gov |
| Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,528,360 | September 15, 2016 | May 31, 2025 | CHOU, STELLA T | reporter.nih.gov |
| Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,527,128 | September 20, 2016 | May 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| The Genetic Architecture of Human Facial Morphology | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,521,882 | July 14, 2017 | February 28, 2026 | WEINBERG, SETH M | reporter.nih.gov |
| Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,518,197 | July 1, 2020 | June 30, 2025 | DEININGER, MICHAEL W. | reporter.nih.gov |
| Prenatal Origins of Neurometabolic Consequences | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,517,422 | September 1, 2021 | July 31, 2026 | DEVASKAR, SHERIN U | reporter.nih.gov |
| Neuronal activity-responsive DNA repair mechanisms and cognitive aging | NIH | National Institute on Aging | 2024 | $2,516,316 | September 1, 2024 | August 31, 2027 | GREENBERG, MICHAEL ELDON | reporter.nih.gov |
| Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,512,001 | July 1, 2016 | May 31, 2026 | ZHAO, YOU-YANG | reporter.nih.gov |
| Molecular and Cellular Dissection of the Pathogenesis of Herpes Simplex Encephalitis with iPSC-Derived CNS and PNS Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,509,626 | September 20, 2010 | March 31, 2025 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Uncovering the role for MSI2 network in hematopoietic stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,505,616 | September 15, 2014 | June 30, 2025 | KHARAS, MICHAEL | reporter.nih.gov |
| Editing Alveolar Progenitor Cells for Correction of Monogenic Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,504,499 | September 23, 2016 | May 31, 2025 | WHITSETT, JEFFREY A | reporter.nih.gov |
| Targeting Aldehyde Dehydrogenase for Cancer Prevention | NIH | National Cancer Institute | 2021 to 2024 | $2,499,798 | April 15, 2020 | March 31, 2026 | ROBERTSON, GAVIN P. | reporter.nih.gov |
| Fine-scale Spatiotemporal Mapping of Cellular Regulatory Networks Directing Heart Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,499,248 | August 1, 2020 | July 31, 2025 | CHI, NEIL C | reporter.nih.gov |
| Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,498,183 | September 30, 2020 | August 31, 2025 | PHILLIPS-CREMINS, JENNIFER ELIZABETH | reporter.nih.gov |
| Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,496,816 | September 18, 2020 | August 31, 2025 | LI, WENBO | reporter.nih.gov |
| Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4 Diversity Supplement | NIH | National Institute on Aging | 2022 to 2024 | $2,493,260 | May 15, 2022 | April 30, 2025 | YASSINE, HUSSEIN N | reporter.nih.gov |
| Using a SMART Design to Optimize PTSD Symptom Management Strategies Among Cancer Survivors | NIH | National Cancer Institute | 2021 to 2024 | $2,482,100 | December 1, 2019 | November 30, 2025 | SMITH, SOPHIA K. | reporter.nih.gov |
| Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD | NIH | National Institute on Aging | 2022 | $2,481,834 | August 2, 2022 | July 31, 2025 | ALBERS, MARK W | reporter.nih.gov |
| Epigenetics and 3D Structure of miR-10b/HoxD Locus in the Brain and Malignant Glioma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,479,682 | September 15, 2020 | July 31, 2025 | KRICHEVSKY, ANNA M. | reporter.nih.gov |
| Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,476,283 | December 15, 2020 | November 30, 2025 | KOTTON, DARRELL N. | reporter.nih.gov |
| Personalizing Class I anti-Arrhythmic Drug Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,473,840 | April 1, 2020 | March 31, 2026 | SILVA, JONATHAN R | reporter.nih.gov |
| HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,470,488 | July 1, 2020 | April 30, 2026 | HO, WENZHE | reporter.nih.gov |
| Lung leukocytes promote alveolar epithelial regeneration after severe injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,469,157 | May 1, 2020 | April 30, 2026 | ARPAIA, NICHOLAS | reporter.nih.gov |
| Dissecting the role of the dentate gyrus microcircuit to improve cognitive discrimination in aging and Alzheimer's Disease | NIH | National Institute on Aging | 2023 | $2,467,494 | December 15, 2022 | November 30, 2025 | LOSONCZY, ATTILA | reporter.nih.gov |
| Regulation of endothelial cell specification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,466,084 | February 15, 2021 | January 31, 2025 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Characterizing Emerging Humanized Immune Mouse Models for the study of transplant rejection and infectious disease pathology (Epstein Barr Virus) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,464,113 | February 2, 2021 | August 30, 2024 | BROWN, MATTHEW E | reporter.nih.gov |
| Mechanism of transplanted neonatal cardiac progenitor cells to repair ischemic myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,462,741 | April 20, 2014 | August 31, 2025 | SCHUMACKER, PAUL T | reporter.nih.gov |
| Brain lymphatic activation for craniosynostosis and Alzheimer’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,461,369 | June 1, 2024 | May 31, 2027 | CHEN, JIANFU | reporter.nih.gov |
| Identifying pathways required for integration of kidney organoid and host epithelia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,461,009 | September 1, 2020 | May 31, 2025 | DRUMMOND, IAIN A. | reporter.nih.gov |
| Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,456,170 | August 1, 2020 | May 31, 2025 | NOVITCH, BENNETT G | reporter.nih.gov |
| Characterization of Neural Stem Cells in Adult Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,454,507 | April 1, 1990 | March 31, 2026 | ALVAREZ-BUYLLA, ARTURO | reporter.nih.gov |
| Biochemistry of Leukemia Virus Core-Binding Factor | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,451,198 | August 10, 1993 | June 30, 2025 | SPECK, NANCY | reporter.nih.gov |
| Emergency Myelopoiesis Pathways in the Control of Blood Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,450,418 | April 1, 2017 | March 31, 2025 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| Role of central and peripheral immune crosstalk in FTD-Grn neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,446,942 | August 17, 2022 | July 30, 2025 | TANSEY, MARIA DE LOURDES GAMEZ | reporter.nih.gov |
| Higher Order Chromatin and Genetic Risk for Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2023 | $2,446,779 | January 15, 2015 | July 31, 2025 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Humanized Mouse Avatars for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,439,759 | September 25, 2014 | May 31, 2024 | GREINER, DALE LESLIE | reporter.nih.gov |
| Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,439,463 | August 1, 2012 | April 30, 2024 | KAUFMAN, DIXON B | reporter.nih.gov |
| Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,438,515 | January 5, 2021 | December 31, 2025 | HSU, KATHARINE C | reporter.nih.gov |
| Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,438,130 | February 1, 2021 | January 31, 2024 | SIGURDSSON, EINAR M | reporter.nih.gov |
| The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity | NIH | National Cancer Institute | 2021 to 2024 | $2,436,646 | February 10, 2020 | January 31, 2026 | BOUSSIOTIS, VASSILIKI A | reporter.nih.gov |
| BMP2 Regulation of Periosteal Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,436,018 | August 1, 2020 | April 30, 2026 | ROSEN, VICKI | reporter.nih.gov |
| A Gata456 Pipeline of Discovery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,432,169 | January 10, 2017 | December 31, 2023 | EVANS, TODD R | reporter.nih.gov |
| Stem cells for therapeutics discovery in genetic blood disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,429,809 | September 23, 2016 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Function of Putative Determinant in Hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,418,427 | August 1, 1993 | June 30, 2026 | BIEKER, JAMES J | reporter.nih.gov |
| The role of mitochondria in hematopoietic stem cell self-renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,417,109 | January 1, 2021 | December 31, 2024 | FILIPPI, MARIE-DOMINIQUE | reporter.nih.gov |
| Role of O-GlcNAcome on Breast Cancer Initiating Cells | NIH | National Cancer Institute | 2021 to 2024 | $2,414,370 | March 1, 2020 | February 28, 2025 | REGINATO, MAURICIO J. | reporter.nih.gov |
| Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,414,163 | February 1, 2019 | January 31, 2024 | XAVIER, JOAO | reporter.nih.gov |
| Novel tools for in vitro electrophysiology and neurotrauma modeling | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,414,021 | August 17, 2020 | January 31, 2026 | FINAN, JOHN D | reporter.nih.gov |
| Gene regulatory networks for heart development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,410,652 | January 1, 2021 | December 31, 2025 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Alzheimer's disease-specific extracellular vesicles: from pathology to novel biomarker discovery | NIH | National Institute on Aging | 2023 | $2,399,582 | September 1, 2023 | August 31, 2026 | MACHAIRAKI, VASILIKI | reporter.nih.gov |
| Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing | NIH | National Institute on Aging | 2023 | $2,394,473 | May 15, 2023 | April 30, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,388,592 | September 21, 2016 | May 31, 2025 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,385,538 | September 15, 2017 | February 28, 2024 | SVENDSEN, CLIVE NIELS | reporter.nih.gov |
| Regulation of Ribosome Biogenesis in Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,385,337 | September 18, 2020 | August 31, 2025 | TONG, WEI | reporter.nih.gov |
| CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,382,655 | April 1, 2021 | March 31, 2026 | WANG, YIGANG | reporter.nih.gov |
| Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool. | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,380,820 | September 26, 2019 | July 31, 2025 | MAIDMENT, NIGEL T | reporter.nih.gov |
| The 4D nucleome of muscle regeneration in ischemia-induced tissue damage and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,377,116 | September 20, 2020 | August 31, 2025 | DIAO, YARUI | reporter.nih.gov |
| Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,376,851 | September 1, 2020 | July 31, 2026 | KIM, DEOK-HO | reporter.nih.gov |
| Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,375,761 | May 1, 2020 | April 30, 2026 | ZHANG, HANRUI | reporter.nih.gov |
| Genome Wide Association Study for Childhood Obesity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,372,606 | July 15, 2008 | June 30, 2026 | GRANT, STRUAN F A | reporter.nih.gov |
| Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,371,262 | August 20, 2021 | June 30, 2026 | QUE, JIANWEN | reporter.nih.gov |
| Developing Human Pluripotent Stem Cell Tools for Region-Specific Pain Circuits | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,370,000 | September 6, 2024 | August 31, 2027 | IYER, NISHA | reporter.nih.gov |
| Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,367,083 | February 15, 2021 | January 31, 2026 | GOMPERTS, BRIGITTE N | reporter.nih.gov |
| Uncovering molecular effectors of mammalian aging | NIH | National Institute on Aging | 2021 to 2022 | $2,366,000 | September 30, 2018 | May 19, 2025 | WAGERS, AMY JO | reporter.nih.gov |
| C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches | NIH | National Institute on Aging | 2021 to 2022 | $2,365,559 | May 1, 2021 | April 30, 2024 | CONKLIN, BRUCE R | reporter.nih.gov |
| Synaptopathy and Pathogenesis in Frontotemporal Dementia: Role of CYLD | NIH | National Institute on Aging | 2023 | $2,364,013 | June 1, 2023 | May 31, 2026 | YAO, WEI-DONG | reporter.nih.gov |
| Regulation of HIV latency by microglial-neuronal interactions | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,363,459 | September 15, 2019 | July 31, 2025 | KARN, JONATHAN | reporter.nih.gov |
| Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease | NIH | National Institute on Aging | 2021 | $2,360,820 | March 1, 2021 | February 29, 2024 | RAJ, TOWFIQUE | reporter.nih.gov |
| Generation of four-chambered hearts through organoid fusions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,358,480 | September 1, 2024 | August 31, 2026 | LI, GUANG | reporter.nih.gov |
| Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $2,355,934 | February 15, 2018 | January 31, 2025 | LEONG, KAM W | reporter.nih.gov |
| Multipotent ABCB5-positive cell therapeutics for corneal disease | NIH | National Eye Institute | 2021 to 2022 | $2,352,662 | April 1, 2018 | January 31, 2024 | FRANK, NATASHA Y | reporter.nih.gov |
| Vsx2 Dependent Regulation of Retinal Progenitor Cell Properties | NIH | National Eye Institute | 2021 to 2024 | $2,351,133 | August 1, 2003 | July 31, 2025 | LEVINE, EDWARD M | reporter.nih.gov |
| Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,348,652 | February 13, 2020 | July 31, 2025 | LANGE, CAROL A | reporter.nih.gov |
| Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,348,133 | September 1, 2019 | July 31, 2025 | RANA, TARIQ M | reporter.nih.gov |
| Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,344,291 | August 18, 2023 | July 31, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Molecular Aspects of Cytomegalovirus Latency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,342,650 | December 1, 1984 | January 31, 2028 | HANCOCK, MEAGHAN H | reporter.nih.gov |
| Mesenchymal modulation of epithelial metaplasia in lung fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,340,812 | February 1, 2021 | December 31, 2024 | PENG, TIEN | reporter.nih.gov |
| Targeting the genotype to phenotype link in HCM as a therapeutic strategy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,339,175 | March 1, 2021 | February 28, 2026 | MERCOLA, MARK | reporter.nih.gov |
| Developmental Origin, Injury and Epigenomic Regulation of NF1-Associated Peripheral Nerve Sheath Tumors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,339,120 | April 15, 2021 | June 30, 2024 | ZHU, YUAN | reporter.nih.gov |
| Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,334,876 | July 15, 2020 | June 30, 2026 | FREEDMAN, BENJAMIN SOLOMON | reporter.nih.gov |
| 2/7-Collaborative genomic studies of Tourette Disorder | NIH | National Institute of Mental Health | 2021 to 2022 | $2,333,736 | July 27, 2018 | September 30, 2023 | STATE, MATTHEW W. | reporter.nih.gov |
| Integrated Cellular and Tissue Engineering for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,333,316 | September 15, 2016 | May 31, 2025 | ZHANG, JIANYI | reporter.nih.gov |
| Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,332,346 | September 15, 2020 | December 31, 2022 | TSE, HUBERT M | reporter.nih.gov |
| Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,328,420 | September 20, 2019 | May 31, 2024 | SYKES, MEGAN | reporter.nih.gov |
| Targeting Aging to prevent Alzheimer's Disease: the Geroscience Approach | NIH | National Institute on Aging | 2021 to 2024 | $2,327,496 | April 15, 2020 | September 30, 2025 | LITHGOW, GORDON J | reporter.nih.gov |
| Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,325,780 | April 20, 2021 | March 31, 2026 | SHLOMCHIK, WARREN D | reporter.nih.gov |
| Nextgen AD Models, Endotypes, and Screening | NIH | National Institute on Aging | 2024 | $2,319,456 | June 1, 2024 | May 31, 2027 | SUBRAMANIAM, SHANKAR | reporter.nih.gov |
| Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development | NIH | National Cancer Institute | 2021 to 2024 | $2,319,039 | September 1, 2020 | August 31, 2025 | SLINGERLAND, JOYCE MARIE | reporter.nih.gov |
| Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality | NIH | National Cancer Institute | 2021 to 2024 | $2,315,110 | September 3, 2018 | January 31, 2026 | SORROR, MOHAMED | reporter.nih.gov |
| Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease | NIH | National Institute of Mental Health | 2021 to 2023 | $2,314,430 | July 18, 2019 | April 30, 2025 | FANG, GANG | reporter.nih.gov |
| Gut microbes modulate immune pathways in intestinal stem cells to influence their lineage | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,311,160 | June 12, 2020 | May 31, 2026 | BUCHON, NICOLAS | reporter.nih.gov |
| A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,306,928 | July 15, 2020 | June 30, 2026 | TAYLOR, D. LANSING | reporter.nih.gov |
| Transplantation of MHC Homozygous Vascular Progenitors in Primates | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,302,970 | September 20, 2016 | May 31, 2025 | SLUKVIN, IGOR I. | reporter.nih.gov |
| T cell invasion of the stem cell compartment during immune-mediated GI damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,299,846 | January 1, 2021 | December 31, 2025 | HANASH, ALAN M | reporter.nih.gov |
| A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,299,186 | July 15, 2021 | June 30, 2026 | MOLL, UTE MARTHA | reporter.nih.gov |
| Engineering optimization and scaling enables high quality pancreatic islet cryopreservation for banking and transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,294,596 | September 22, 2021 | July 31, 2025 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Cell Therapy for Neuroprotection in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,294,475 | December 15, 2017 | April 30, 2027 | ISHIBASHI, NOBUYUKI | reporter.nih.gov |
| Understanding and targeting bone marrow microenvironment in myelofibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,288,703 | January 1, 2021 | December 31, 2025 | DING, LEI | reporter.nih.gov |
| Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management | NIH | National Center for Advancing Translational Sciences | 2021 | $2,287,391 | September 26, 2019 | July 31, 2025 | GOLD, MICHAEL S | reporter.nih.gov |
| ApoE, lipid and immune mechanisms of human neurons and glia | NIH | National Institute on Aging | 2023 | $2,284,296 | December 15, 2022 | November 30, 2025 | ISACSON, OLE | reporter.nih.gov |
| Sex-dependent role of 5HT1A receptors in adult neurogenesis and hippocampal function | NIH | National Institute of Mental Health | 2021 to 2024 | $2,284,076 | February 1, 2020 | November 30, 2025 | SONG, JUAN | reporter.nih.gov |
| Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,281,119 | September 1, 2020 | June 30, 2025 | LARGAESPADA, DAVID ANDREW | reporter.nih.gov |
| Artery biomechanics and vascular damage in sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,274,529 | May 1, 2021 | April 30, 2026 | BOTCHWEY, EDWARD A. | reporter.nih.gov |
| MicroRNA regulation of neural tube closure | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,271,604 | March 10, 2020 | February 28, 2025 | PARCHEM, RONALD J | reporter.nih.gov |
| Transcriptional Regulation of Lung Alveolar Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,270,370 | February 1, 2021 | December 31, 2024 | MORRISEY, EDWARD E | reporter.nih.gov |
| Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,267,763 | August 1, 2021 | July 31, 2025 | KWON, CHULAN | reporter.nih.gov |
| Role of the local vascular microenvironment in the bone marrow response to inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,264,190 | July 20, 2021 | December 31, 2024 | LUCAS, DANIEL | reporter.nih.gov |
| Understanding the role of stellate cells in the liver hematopoietic stem cell niche | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,262,921 | August 1, 2020 | July 31, 2025 | DING, LEI | reporter.nih.gov |
| Temporal program for cell fate specification in the mouse embryo | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,262,020 | August 1, 2020 | July 31, 2025 | ZERNICKA-GOETZ, MAGDALENA | reporter.nih.gov |
| Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,260,661 | September 15, 2020 | June 30, 2025 | CHEN, SHUIBING | reporter.nih.gov |
| Fibroblast Growth Factor and Energy Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,257,939 | July 3, 2015 | March 31, 2026 | TSENG, YU-HUA | reporter.nih.gov |
| Mechanisms of oxysterol-induced oligodendrogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,255,433 | December 15, 2019 | November 30, 2024 | BENNER, ERIC J | reporter.nih.gov |
| Loss of TDP-43 disrupts the prefrontal neural activity and circuitry: relevance for TDP-43 linked ADRD | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,255,378 | September 19, 2022 | August 31, 2025 | LI, YUN | reporter.nih.gov |
| Tympanic membrane progenitor cells in homeostasis in injury | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,250,702 | April 25, 2020 | March 31, 2026 | TWARD, AARON | reporter.nih.gov |
| Epigenetics of inner ear neurosensory cell development | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,250,638 | July 1, 2020 | June 30, 2025 | MARTIN, DONNA M. | reporter.nih.gov |
| Functional Genomics of Tibetan Adaptations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,246,453 | April 1, 2014 | June 30, 2025 | DI RIENZO, ANNA | reporter.nih.gov |
| Development of ASH1L inhibitors for acute leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,243,021 | December 1, 2019 | November 30, 2025 | GREMBECKA, JOLANTA | reporter.nih.gov |
| Blockade of IL-23 for the Prevention of Graft Versus Host Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,237,924 | April 15, 2021 | March 31, 2026 | DROBYSKI, WILLIAM R. | reporter.nih.gov |
| Functional Validation of TDP-43 splicing repression for frontotemporal degeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,237,856 | September 1, 2021 | August 31, 2023 | WONG, PHILIP C | reporter.nih.gov |
| PCTC Administrative Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,233,284 | September 20, 2016 | May 31, 2025 | TERRIN, MICHAEL L | reporter.nih.gov |
| Gene editing ELANE to understand and treat severe congenital neutropenia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,233,070 | January 1, 2020 | December 31, 2024 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Contribution of macrophages in the HSC niche | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,230,269 | April 1, 2021 | February 28, 2026 | STEIDL, ULRICH | reporter.nih.gov |
| Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstruction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,227,502 | January 1, 2020 | December 31, 2025 | OZBOLAT, IBRAHIM | reporter.nih.gov |
| The roles of regional specialization, mechanical forces and epigenetic memory after perturbation and injury of the intestinal stem cell microenvironment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,226,844 | September 5, 2014 | August 31, 2024 | KLEIN, OPHIR D | reporter.nih.gov |
| Stem Cells and Aging | NIH | National Institute of General Medical Sciences | 2021 | $2,226,780 | July 1, 2017 | June 30, 2024 | QUESENBERRY, PETER J. | reporter.nih.gov |
| Genetic Regulation of Nonalcoholic Fatty Liver Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,221,739 | June 8, 2021 | March 31, 2026 | MEDINA, MARISA WONG | reporter.nih.gov |
| Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,218,334 | January 17, 2017 | December 31, 2025 | KIEM, HANS-PETER | reporter.nih.gov |
| Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,211,941 | December 20, 2019 | May 31, 2025 | JAIN, MANEESH | reporter.nih.gov |
| Development of a Synthetic, Cell-Permeable Peptide for the Inhibition of CDK5-p25 Hyperactivity in Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,210,678 | September 22, 2021 | August 31, 2024 | WERNER, JOHN KENT | reporter.nih.gov |
| Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,208,551 | July 15, 2020 | May 2, 2024 | NIXON, DOUGLAS F | reporter.nih.gov |
| Cell autonomous and non-cell autonomous phenotypes due to genetic risk for late onset Alzheimers disease | NIH | National Institute on Aging | 2021 | $2,207,391 | May 1, 2021 | April 30, 2024 | POON, WAYNE W | reporter.nih.gov |
| Developmental Heterogeneity of Pulmonary Endothelial Phenotype at Single Cell Resolution | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,206,652 | September 15, 2021 | December 1, 2024 | ALVIRA, CRISTINA MARIA | reporter.nih.gov |
| AML mutation-guided drugging of DNA repair | NIH | National Cancer Institute | 2021 to 2024 | $2,200,960 | March 1, 2020 | January 31, 2026 | SKORSKI, TOMASZ | reporter.nih.gov |
| Mechanism of action of PTH: New signaling components that regulate bone formation and bone marrow fat | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,199,383 | May 5, 2020 | March 31, 2026 | BARON, ROLAND E | reporter.nih.gov |
| Biology of Submucosal Gland Stem Cells in the Airway | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,198,254 | June 20, 2022 | May 31, 2025 | ENGELHARDT, JOHN F | reporter.nih.gov |
| A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,198,065 | July 1, 2020 | November 30, 2025 | SVENDSEN, CLIVE NIELS | reporter.nih.gov |
| Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines | NIH | National Cancer Institute | 2021 to 2024 | $2,196,107 | August 1, 1981 | December 31, 2024 | GOFF, STEPHEN PAINE | reporter.nih.gov |
| Mechanisms of epithelial repair and remodeling in pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,193,295 | July 15, 2020 | June 30, 2025 | KROPSKI, JONATHAN ANDREW | reporter.nih.gov |
| A Novel Role for NFATC1 in Modulating Cardiac Excitability | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,192,974 | July 1, 2020 | June 30, 2025 | TRISTANI-FIROUZI, MARTIN | reporter.nih.gov |
| Alternative RNA splicing events contribute to the onset of islet dysfunction in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,191,256 | September 15, 2020 | June 30, 2024 | SUSSEL, LORI | reporter.nih.gov |
| Molecular Segregation of Parkinson’s Disease by Patient-Derived Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,183,720 | June 1, 2020 | May 31, 2026 | FENG, JIAN | reporter.nih.gov |
| Genetic mechanisms of type 1 diabetes risk in stress-induced pancreatic islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,181,407 | August 1, 2019 | May 31, 2023 | GAULTON, KYLE JEFFRIE | reporter.nih.gov |
| Mechanisms of gene regulation and RNA processing in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,181,405 | July 1, 2020 | June 30, 2025 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Novel patient-derived 3D platform for detecting TDP-43 proteinopathy and associated biomarkers for ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,175,360 | February 15, 2022 | January 31, 2025 | GHAFFARI, LAYLA | reporter.nih.gov |
| Resilience to Alzheimer's disease by targeting adult hippocampal neurogenesis | NIH | National Institute on Aging | 2024 | $2,173,794 | September 1, 2024 | August 31, 2027 | CHOI, SE HOON | reporter.nih.gov |
| Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,173,391 | June 1, 2020 | May 31, 2025 | ABDEL-WAHAB, OMAR | reporter.nih.gov |
| A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,172,600 | August 15, 2020 | July 31, 2025 | AWAD, HANI A | reporter.nih.gov |
| Muscle progenitor cell-based implants for dynamic laryngeal muscle reconstruction | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,172,460 | July 15, 2015 | June 30, 2025 | HALUM, STACEY L. | reporter.nih.gov |
| miR-223 regulates endothelial to hematopoietic transition | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,165,334 | April 15, 2020 | January 31, 2025 | NICOLI, STEFANIA | reporter.nih.gov |
| Sox Proteins Modulate Genomic Specificity of B-catenin Regulated Transcription in the Developing Gut | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,163,911 | January 15, 2021 | December 31, 2025 | ZORN, AARON M | reporter.nih.gov |
| The µSiM-hNVU - a human BBB platform for the study of brain injury mechanisms during systemic infection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,162,325 | September 3, 2020 | August 31, 2025 | MCGRATH, JAMES L | reporter.nih.gov |
| Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress | NIH | National Cancer Institute | 2021 to 2022 | $2,160,078 | September 17, 2018 | August 31, 2024 | WILLEY, CHRISTOPHER D | reporter.nih.gov |
| Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential | NIH | National Cancer Institute | 2021 to 2023 | $2,160,040 | December 3, 2018 | November 30, 2024 | LAIRD, PETER W | reporter.nih.gov |
| Non-coding RNA regulation of early neural development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,159,490 | December 1, 2019 | November 30, 2025 | NISWANDER, LEE A. | reporter.nih.gov |
| Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer | NIH | National Cancer Institute | 2021 to 2023 | $2,159,273 | June 4, 2018 | November 30, 2023 | DUCKETT, DEREK RONALD | reporter.nih.gov |
| Neurotoxicity of particulate matter and its interaction with APOE in neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,159,148 | September 20, 2022 | August 31, 2025 | KITAZAWA, MASASHI | reporter.nih.gov |
| The Role of PHF6 in HSC self-renewal and myeloid expansion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,150,399 | January 6, 2021 | December 31, 2025 | PARALKAR, VIKRAM R. | reporter.nih.gov |
| Role of SCN1B in Inherited Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,149,827 | February 1, 2011 | January 31, 2025 | ISOM, LORI L. | reporter.nih.gov |
| Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $2,147,498 | August 15, 2019 | July 31, 2024 | GREINER, DALE LESLIE | reporter.nih.gov |
| The regulation of thrombopoietin levels | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,146,386 | August 1, 2021 | April 30, 2025 | KHORIATY, RAMI | reporter.nih.gov |
| Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling | NIH | National Cancer Institute | 2021 to 2024 | $2,143,591 | September 3, 2020 | May 31, 2026 | CHAPKIN, ROBERT STEPHEN | reporter.nih.gov |
| Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical Care | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,141,117 | July 1, 2020 | June 30, 2025 | QYANG, YIBING | reporter.nih.gov |
| Improvement of Animal Models for TMJ Stem Cell-Based Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $2,135,816 | July 15, 2019 | April 30, 2025 | EMBREE, MILDRED CHRISTINE | reporter.nih.gov |
| Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2024 | $2,135,509 | August 1, 2020 | July 31, 2025 | KAPAHI, PANKAJ | reporter.nih.gov |
| Toward Understanding the Role of the Polycomb Complex in Skin Control | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,130,652 | February 1, 2016 | August 31, 2025 | EZHKOVA, ELENA | reporter.nih.gov |
| Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's Disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,124,884 | February 1, 2020 | October 31, 2025 | HARRISON, FIONA EDITH | reporter.nih.gov |
| Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations | NIH | National Cancer Institute | 2021 to 2024 | $2,123,250 | June 1, 2020 | May 31, 2025 | ZHU, HAO | reporter.nih.gov |
| Human CDX2 Cells and Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,116,925 | July 21, 2020 | May 31, 2025 | CHAUDHRY, HINA W | reporter.nih.gov |
| Development of CRISPR/Cas9-based exon-skipping strategies for the treatment of USH-associated deafness | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2024 | $2,113,099 | August 22, 2022 | June 30, 2027 | LIU, XUE Z | reporter.nih.gov |
| Defining post-transcriptional regulons in intestinal epithelial regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,109,090 | April 1, 2020 | March 31, 2026 | HAMILTON, KATHRYN ELIZABETH | reporter.nih.gov |
| UCSD Biomedical Scientist Career Development Program in Glycoscience | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,105,436 | July 1, 2018 | June 30, 2024 | ESKO, JEFFREY D | reporter.nih.gov |
| Altered Hippocampal Neurogenesis and Cognition via Maneb-mediated Changes in the Thiol Redox Proteome. | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $2,104,664 | March 1, 2017 | February 28, 2026 | ROEDE, JAMES R | reporter.nih.gov |
| Modeling Alzheimer's disease genetic variants in hiPSC | NIH | National Institute on Aging | 2021 to 2023 | $2,102,361 | May 1, 2019 | February 28, 2025 | DUAN, JUBAO | reporter.nih.gov |
| Genetic Regulation of Inner, Middle and Outer Ear Development | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,101,738 | March 22, 2013 | November 30, 2025 | GROVES, ANDREW K | reporter.nih.gov |
| Cardiac Mechanisms of Sudden Unexpected Death in Epilepsy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,101,543 | July 1, 2020 | June 30, 2025 | ISOM, LORI L. | reporter.nih.gov |
| Targeting Dyrk1a to Promote Donor-independent Platelet Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,097,567 | February 20, 2020 | January 31, 2025 | GOLDFARB, ADAM N. | reporter.nih.gov |
| Targeting cancer stem cells in JAK2V617F induced neoplasm | NIH | National Cancer Institute | 2021 to 2024 | $2,096,959 | February 15, 2020 | January 31, 2025 | LI, SHAOGUANG | reporter.nih.gov |
| Notch/Robo Regulated Mechanisms Governing Cell Fate Acquisition | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,096,618 | April 1, 2020 | December 31, 2025 | HINCK, LINDSAY E | reporter.nih.gov |
| Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,096,374 | August 1, 2014 | May 31, 2025 | SOTO-GUTIERREZ, ALEJANDRO | reporter.nih.gov |
| Mechanisms and Regulation of Brain Iron Uptake | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,095,116 | December 1, 2019 | November 30, 2025 | CONNOR, JAMES ROBERT | reporter.nih.gov |
| The role of Myt1l in the developing and adult mouse brain | NIH | National Institute of Mental Health | 2021 to 2023 | $2,094,570 | April 1, 2019 | January 31, 2024 | WERNIG, MARIUS | reporter.nih.gov |
| Cell Type and Regional Vulnerability in Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,094,351 | August 1, 2021 | July 31, 2024 | TEMPLE, SALLY | reporter.nih.gov |
| Deciphering Trophic Signaling Programs Governing Peripheral Sensory Nervous System Development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,093,638 | December 1, 2019 | November 30, 2025 | ZUNDER, ELI | reporter.nih.gov |
| Extending the temporal and spatial capabilities of single-molecule methods | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,093,498 | September 1, 2021 | August 31, 2025 | CHU, STEVEN | reporter.nih.gov |
| Understanding Frontotemporal Dementia Using Drosophila and iPSC Models | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,086,468 | April 15, 2017 | March 31, 2025 | GAO, FEN-BIAO | reporter.nih.gov |
| Modeling CNS dynamics in HIV infection and cannabinoids with forebrain organoids | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,085,642 | August 1, 2019 | June 30, 2025 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,085,362 | January 5, 2023 | December 31, 2025 | WAINGER, BRIAN JASON | reporter.nih.gov |
| Ex vivo analysis of human brain tumor cells in a microvascular niche model | NIH | National Cancer Institute | 2021 to 2024 | $2,082,785 | February 4, 2020 | January 31, 2025 | FAN, RONG | reporter.nih.gov |
| Targeting the Circadian Rhythm in Glioblastoma Stem Cells (R01CA238662) | NIH | National Cancer Institute | 2021 to 2024 | $2,081,567 | July 1, 2021 | November 30, 2024 | RICH, JEREMY N | reporter.nih.gov |
| Function of RUNX1 in diverse Down syndrome tissues | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,081,565 | September 1, 2023 | August 31, 2024 | ALLEN, MARY A | reporter.nih.gov |
| Mechanisms of Regulation of the m6A mRNA Methylation Machinery | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,080,305 | August 14, 2020 | June 30, 2025 | ALARCON, CLAUDIO R | reporter.nih.gov |
| Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection | NIH | National Eye Institute | 2021 to 2024 | $2,079,783 | January 1, 2021 | December 31, 2025 | ARUMUGASWAMI, VAITHILINGARAJA | reporter.nih.gov |
| The cis-regulatory grammar and epigenetic control of human interneuron progenitor specification | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,079,315 | June 15, 2021 | May 31, 2026 | KROLL, KRISTEN L | reporter.nih.gov |
| Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,073,245 | July 1, 2021 | May 31, 2026 | AGARWAL, ANUPRIYA | reporter.nih.gov |
| Cellular Reservoirs of HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,070,157 | September 23, 2019 | August 31, 2025 | COLLINS, KATHLEEN L. | reporter.nih.gov |
| Mechanisms regulating functional heterogeneity of subcutaneous adipose tissues in women | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,068,261 | July 8, 2019 | April 30, 2025 | FRIED, SUSAN K | reporter.nih.gov |
| Oligodendrocyte Progenitors and Mechanisms of Human Vascular White Matter Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,066,705 | July 15, 2019 | April 30, 2026 | BACK, STEPHEN ARTHUR | reporter.nih.gov |
| Connecting 3D genome misfolding to transcriptional silencing in fragile X syndrome | NIH | National Institute of Mental Health | 2021 to 2024 | $2,066,257 | August 15, 2019 | January 31, 2029 | PHILLIPS-CREMINS, JENNIFER ELIZABETH | reporter.nih.gov |
| Neuronal ABCA7 loss of function and Alzheimer’s disease | NIH | National Institute on Aging | 2023 | $2,063,098 | June 1, 2023 | May 31, 2026 | KANEKIYO, TAKAHISA | reporter.nih.gov |
| Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression | NIH | National Cancer Institute | 2021 to 2023 | $2,060,694 | February 19, 2019 | January 31, 2024 | MOSTOSLAVSKY, RAUL | reporter.nih.gov |
| Neural Circuit Control of Postnatal Quiescent Neural Stem Cell Activation | NIH | National Institute of Mental Health | 2021 to 2024 | $2,054,748 | November 19, 2014 | April 30, 2025 | YIN, HENRY | reporter.nih.gov |
| The Role of PRDM16 in Cardiac Development and Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,054,619 | July 15, 2020 | May 31, 2025 | BOUDINA, SIHEM | reporter.nih.gov |
| Balancing Airway Progenitor versus Progeny: a Pathway from Mitochondria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,054,106 | August 20, 2021 | June 30, 2026 | SUN, XIN | reporter.nih.gov |
| Bone marrow-targeted extracellular vesicles as a novel non-viral gene editor delivery platform | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $2,051,588 | July 1, 2022 | May 31, 2025 | THON, JONATHAN N | reporter.nih.gov |
| Treating Kidney Injury by Modulating Heat Shock Proteins Using Soundwaves Combined with Mesenchymal Stem Cells and Their Extracellular Vesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,048,853 | August 30, 2021 | July 31, 2025 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Cancer patient on a chip | NIH | National Cancer Institute | 2021 to 2024 | $2,041,238 | July 15, 2020 | June 30, 2025 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| Neuronal quality control and neuroprotection in tauopathies | NIH | National Institute on Aging | 2021 to 2024 | $2,040,301 | August 1, 2007 | April 30, 2026 | CHU, CHARLEEN T | reporter.nih.gov |
| Spatial Control of Myeloid Differentiation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,038,767 | August 15, 2021 | December 31, 2024 | LUCAS, DANIEL | reporter.nih.gov |
| Investigating a master regulator of large intestine stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,038,576 | August 1, 2021 | July 31, 2025 | RAFII, SHAHIN | reporter.nih.gov |
| Aortic Valve Disease: Mechanisms and Therapeutic Approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,037,372 | February 10, 2020 | January 31, 2025 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Characterization of progenitor populations in adult taste epithelium | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,037,331 | July 1, 2020 | June 30, 2026 | BARLOW, LINDA A | reporter.nih.gov |
| Structure function relationships from deep mutational scanning in human cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,035,543 | January 1, 2020 | December 31, 2024 | ASHLEY, EUAN A | reporter.nih.gov |
| Investigating epigenetic mechanisms in Down syndrome using human cellular models | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $2,034,753 | April 5, 2023 | March 31, 2026 | BARRETT, LINDY ELISE | reporter.nih.gov |
| Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,034,476 | February 1, 2022 | January 31, 2026 | MCKEON, FRANK D. | reporter.nih.gov |
| Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,034,388 | December 1, 2022 | August 31, 2024 | GEISSE, NICHOLAS ANDREW | reporter.nih.gov |
| Embryonic vascular stem-progenitors for treatment of ischemic retinopathies | NIH | National Eye Institute | 2021 to 2024 | $2,033,849 | February 1, 2021 | January 31, 2026 | ZAMBIDIS, ELIAS T. | reporter.nih.gov |
| A novel epigenetic mechanism in early embryogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,033,719 | April 1, 2020 | March 31, 2026 | XIAO, ZHUO ANDREW | reporter.nih.gov |
| A first in class, mechanism-guided, cell-based therapy for complex regional pain syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,033,135 | September 24, 2022 | August 31, 2025 | CHENG, JIANGUO | reporter.nih.gov |
| Novel mechanisms of vasculogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,033,101 | June 5, 2021 | May 31, 2026 | SUMANAS, SAULIUS | reporter.nih.gov |
| Neurobehavioral, cognitive, and mechanistic effects of intranasally administered neural stem cells and environmental enrichment after cortical impact injury in rats | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,032,869 | September 1, 2021 | August 31, 2025 | KLINE, ANTHONY E. | reporter.nih.gov |
| Dissecting the role of tau glycosylation in Alzheimer's disease | NIH | National Institute on Aging | 2023 | $2,031,054 | April 15, 2023 | March 31, 2026 | WALCZAK, MACIEJ | reporter.nih.gov |
| Functional implications of CPVT1-associated RyR2 mutations in human cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,028,489 | September 1, 2021 | July 31, 2026 | MORAD, MARTIN | reporter.nih.gov |
| Functional analysis of mammalian midbody RNA in post-mitotic signaling functions | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,023,221 | September 16, 2021 | August 31, 2025 | SKOP, AHNA RENEE | reporter.nih.gov |
| Synthetic Mesenchymal Stem Cell Niches for Vascular Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,023,009 | August 15, 2013 | July 31, 2025 | TAN, WEI | reporter.nih.gov |
| Novel mechanism of intestinal stem cell aging | NIH | National Institute on Aging | 2021 to 2024 | $2,022,936 | September 15, 2020 | May 31, 2025 | ZHENG, YI | reporter.nih.gov |
| A stress-induced promoter pause release program in cardiomyocytes protecting against myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,021,907 | December 15, 2019 | November 30, 2024 | ROSENFELD, MICHAEL G | reporter.nih.gov |
| Genetic Analysis of MicroRNA Functions in Skin Stem Cells In Vivo | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,013,300 | July 1, 2014 | November 30, 2025 | YI, RUI | reporter.nih.gov |
| Targeted Small Molecule Inhibitors for Inv(16) Leukemia | NIH | National Cancer Institute | 2021 to 2023 | $2,012,862 | December 1, 2018 | November 30, 2024 | BUSHWELLER, JOHN HACKETT | reporter.nih.gov |
| iPSC-derived Neurovascular Organoids | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,012,834 | April 15, 2020 | March 31, 2026 | LIPPMANN, ETHAN | reporter.nih.gov |
| Signaling Pathways that Regulate Scaling and Regeneration of the Cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,010,981 | February 1, 2015 | January 31, 2026 | JOYNER, ALEXANDRA L. | reporter.nih.gov |
| Chromatin Organization Regulates Osteogenesis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,010,351 | January 6, 2020 | December 31, 2024 | STEIN, GARY S. | reporter.nih.gov |
| Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,008,113 | March 10, 2015 | June 30, 2024 | WU, JOSEPH C. | reporter.nih.gov |
| Exosome educated monocytes for acute radiation syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,007,828 | August 1, 2021 | July 31, 2025 | CAPITINI, CHRISTIAN | reporter.nih.gov |
| Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,006,965 | April 1, 2020 | March 31, 2026 | BASTEPE, MURAT | reporter.nih.gov |
| The role of APP in neurogenesis and AD in Down syndrome | NIH | National Institute on Aging | 2022 | $2,005,131 | September 15, 2022 | August 31, 2025 | LAZAROV, ORLY | reporter.nih.gov |
| Systems analysis of aggressive prostate cancer pathology | NIH | National Cancer Institute | 2021 to 2023 | $2,003,318 | September 1, 2019 | August 31, 2025 | COSTELLO, JAMES CHRISTOPHER | reporter.nih.gov |
| Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,003,229 | April 1, 2020 | March 31, 2026 | ONG, SANG GING | reporter.nih.gov |
| A Catalog of Cell Types and Genomic Elements in Tissues, Organoids and Disease | NIH | National Human Genome Research Institute | 2021 | $2,002,687 | February 1, 2017 | January 31, 2022 | BERNSTEIN, BRADLEY EVAN | reporter.nih.gov |
| Matching panels of in vivo and in vitro model system of pediatric brain tumors | NIH | National Cancer Institute | 2021 to 2024 | $2,001,657 | March 3, 2020 | February 28, 2026 | LI, XIAONAN | reporter.nih.gov |
| TOPIC 414 : SYNTHETIC BIOLOGY GENE CIRCUITS FOR CANCER THERAPY | NIH | National Cancer Institute | 2021 | $1,999,993 | August 1, 2021 | July 31, 2023 | LEE, GARY | reporter.nih.gov |
| Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response | NIH | National Cancer Institute | 2021 to 2024 | $1,999,491 | December 1, 2019 | November 30, 2025 | MEHROTRA, SHIKHAR | reporter.nih.gov |
| Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,998,233 | May 1, 2021 | April 30, 2024 | STEWART, CHARLES ANDREW | reporter.nih.gov |
| Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells | NIH | National Cancer Institute | 2021 to 2024 | $1,998,178 | September 1, 2020 | May 31, 2025 | LI, MING | reporter.nih.gov |
| Cell adhesion-dependent mechanisms of beta cell growth and homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,998,151 | April 1, 2020 | February 28, 2025 | CIRULLI, VINCENZINO | reporter.nih.gov |
| Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome | NIH | National Institute of Mental Health | 2021 to 2023 | $1,997,858 | September 1, 2019 | September 30, 2024 | CUBELLS, JOSEPH F. | reporter.nih.gov |
| Generation of human skin organoids from pluripotency (Admin Supplement) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,996,696 | September 17, 2019 | August 31, 2025 | KOEHLER, KARL RUSSELL | reporter.nih.gov |
| Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target? | NIH | National Cancer Institute | 2021 to 2024 | $1,996,349 | April 1, 2020 | March 31, 2026 | MARCUCCI, GUIDO | reporter.nih.gov |
| Evolving High Potency AAV Vectors for Neuromuscular Genome Editing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,992,277 | September 10, 2018 | July 31, 2024 | ASOKAN, ARAVIND | reporter.nih.gov |
| In Vivo Proof of Concept and Target Identification Using Small Molecule Stimulators of Brown Adipogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,988,528 | July 1, 2020 | July 31, 2024 | BOSS, OLIVIER | reporter.nih.gov |
| Function of the Stem Cell Transcription Factor SOX2 in Prostatic Enlargement | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,988,247 | March 10, 2020 | December 31, 2025 | VANDER GRIEND, DONALD JAMES | reporter.nih.gov |
| Genetic regulation of cardiac inflow tract formation in zebrafish | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,982,777 | May 14, 2021 | April 30, 2025 | YELON, DEBORAH | reporter.nih.gov |
| Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,981,204 | July 15, 2020 | April 30, 2026 | SPEARMAN, PAUL W. | reporter.nih.gov |
| InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $1,980,716 | May 1, 2022 | January 31, 2025 | THELIN, BILL | reporter.nih.gov |
| AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis | NIH | National Cancer Institute | 2021 to 2023 | $1,980,668 | July 1, 2019 | June 30, 2025 | BUSHWELLER, JOHN HACKETT | reporter.nih.gov |
| Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets | NIH | National Cancer Institute | 2021 to 2024 | $1,980,275 | May 1, 2020 | April 30, 2026 | BRAT, DANIEL J | reporter.nih.gov |
| Human Microphysiological Model of Afferent Nociceptive Signaling | NIH | National Center for Advancing Translational Sciences | 2021 | $1,978,863 | September 26, 2019 | January 31, 2025 | MOORE, MICHAEL J | reporter.nih.gov |
| Delirium in Children Undergoing Hematopoietic Stem Cell Transplants | NIH | National Cancer Institute | 2021 to 2024 | $1,975,976 | September 1, 2020 | May 31, 2026 | TRAUBE, CHANI | reporter.nih.gov |
| Gastrin Regulation of Gastric Antral Stem and Corpus Progenitor Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,975,882 | September 23, 2021 | August 31, 2025 | WANG, TIMOTHY CRAGIN | reporter.nih.gov |
| A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,974,527 | March 1, 2021 | February 28, 2025 | RICE, CHARLES M | reporter.nih.gov |
| Combined bioprinting with stem cell technology to regenerate skin burn wounds | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,972,718 | August 1, 2021 | May 31, 2026 | SQUARIZE, CRISTIANE | reporter.nih.gov |
| Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis | NIH | National Cancer Institute | 2021 to 2024 | $1,972,648 | May 1, 2010 | February 28, 2026 | SHEMBADE, NOULA DATTU | reporter.nih.gov |
| Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,972,069 | September 30, 2020 | August 31, 2025 | FARMER, DIANA LEE | reporter.nih.gov |
| Role of novel onco-histone mutations in B-cell malignancies | NIH | National Cancer Institute | 2021 to 2023 | $1,967,972 | August 1, 2019 | July 31, 2025 | CESARMAN, ETHEL | reporter.nih.gov |
| UBE3A gain-of-function and parent-of-origin influence on neurodevelopmental phenotypes | NIH | National Institute of Mental Health | 2021 to 2023 | $1,967,890 | September 1, 2019 | June 30, 2025 | ZYLKA, MARK J. | reporter.nih.gov |
| Molecular characterization of biliverdin IXbeta reductase | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,962,131 | July 1, 2021 | March 31, 2026 | BAHOU, WADIE F | reporter.nih.gov |
| The role of ER associated degradation (ERAD) in hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,953,048 | July 3, 2020 | June 30, 2026 | LI, QING | reporter.nih.gov |
| Defining epithelial polarity cues that direct cell fate | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,952,921 | August 15, 2014 | January 31, 2026 | VARELAS, XARALABOS | reporter.nih.gov |
| Pluripotent Stem Cell Derived 3D Retinas for Studies of Early Onset Retinal Degeneration | NIH | National Eye Institute | 2021 to 2024 | $1,950,685 | April 1, 2020 | March 31, 2026 | WAHLIN, KARL J | reporter.nih.gov |
| Tumor matrix remodeling in anti-myeloma immunity and immunotherapy | NIH | National Cancer Institute | 2021 to 2024 | $1,950,659 | July 1, 2020 | December 31, 2024 | ASIMAKOPOULOS, FOTIOS | reporter.nih.gov |
| New Ways of Targeting K-Ras | NIH | National Cancer Institute | 2021 to 2022 | $1,950,085 | April 1, 2016 | March 31, 2023 | MCCORMICK, FRANK PATRICK | reporter.nih.gov |
| Discovery of small molecule regulators of atrial cardiomyocyte action potential duration to restore normal cardiac rhythm in atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,950,000 | June 10, 2021 | August 31, 2025 | COLAS, ALEXANDRE ROMAIN | reporter.nih.gov |
| Comprehensive Mapping of Long-Range Chromatin Interactions in Humanand Mouse Genomes | NIH | National Human Genome Research Institute | 2021 | $1,949,357 | February 1, 2017 | January 31, 2023 | LEE, CHARLES | reporter.nih.gov |
| DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,948,900 | November 23, 2021 | March 31, 2026 | ZHANG, YI | reporter.nih.gov |
| Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,948,211 | September 30, 2009 | July 31, 2025 | NEWBURGER, JANE W. | reporter.nih.gov |
| Define the effect of CLU SNP on the risk to Alzheimer's disease | NIH | National Institute on Aging | 2022 | $1,942,962 | August 1, 2022 | July 31, 2025 | SHI, YANHONG | reporter.nih.gov |
| Regulatory elements of replication timing and 3D genome organization | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,941,046 | July 1, 2020 | June 30, 2025 | RIVERA-MULIA, JUAN CARLOS | reporter.nih.gov |
| A Novel Approach to Molecular Cell Pathologies of Human Down Syndrome and DS-AD | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,938,999 | September 12, 2017 | March 31, 2026 | LAWRENCE, JEANNE BENTLEY | reporter.nih.gov |
| Investigating the effects of aerobic and resistance training in vivo on skeletal muscle metabolism in vitro in primary human muscle cells (MoTrMyo) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,938,650 | August 1, 2019 | May 31, 2026 | SPARKS, LAUREN MARIE | reporter.nih.gov |
| Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,935,472 | August 22, 2018 | July 31, 2024 | DE OLIVEIRA, ELISEU O. | reporter.nih.gov |
| Endocannabinoid Signaling during Early Pregnancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,933,902 | July 1, 1990 | May 31, 2026 | DEY, SUDHANSU K | reporter.nih.gov |
| Maternal programming of the stem cell-basophil axis for asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,932,227 | July 20, 2020 | June 30, 2025 | GORSKA, MAGDALENA MARIA | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Columbia University Health Sciences | New York, NY | 106 | $117.2 million | 0 | $0 |
| Stanford University | Stanford, CA | 139 | $110.1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 126 | $108.4 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 100 | $101.8 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 112 | $86.9 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 106 | $81.6 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 114 | $75.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 92 | $70.9 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 66 | $68.8 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 72 | $66.6 million | 0 | $0 |
| Washington University | Saint Louis, MO | 84 | $65.6 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 55 | $65.3 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 62 | $62.1 million | 0 | $0 |
| University of Washington | Seattle, WA | 69 | $59.1 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 59 | $55.6 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 58 | $54.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 51 | $53.8 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 15 | $53.4 million | 0 | $0 |
| Yale University | New Haven, CT | 47 | $52 million | 0 | $0 |
| Emory University | Atlanta, GA | 59 | $51.8 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 55 | $51.1 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 62 | $48 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 44 | $47.5 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 42 | $45.6 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 58 | $44.9 million | 0 | $0 |
| Duke University | Durham, NC | 62 | $44.5 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 54 | $43.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 37 | $37 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 48 | $35 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 35 | $35 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 32 | $32.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 40 | $32.2 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 24 | $32.2 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 15 | $31.8 million | 0 | $0 |
| University of California at Davis | Davis, CA | 33 | $31.4 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 19 | $29.5 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 33 | $29.2 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 27 | $28.7 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 40 | $28.3 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 40 | $28.1 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 24 | $28 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 35 | $27.9 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 28 | $27.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 39 | $27.5 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 27 | $27.4 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 45 | $27.1 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 19 | $25.8 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 25 | $24.8 million | 0 | $0 |
| University of Chicago | Chicago, IL | 28 | $24.7 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 21 | $24.7 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 34 | $24.3 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 25 | $23.7 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 30 | $23.5 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 26 | $23.3 million | 0 | $0 |
| Ohio State University | Columbus, OH | 32 | $22.3 million | 0 | $0 |
| Regents of the University of Idaho | Moscow, ID | 1 | $21.9 million | 0 | $0 |
| University of Rochester | Rochester, NY | 31 | $21.7 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 26 | $21.4 million | 0 | $0 |
| Cornell University | Ithaca, NY | 20 | $21.3 million | 0 | $0 |
| Harvard University | Cambridge, MA | 25 | $20.2 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 15 | $19.9 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 16 | $19.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 18 | $19.2 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 7 | $19.2 million | 0 | $0 |
| Augusta University | Augusta, GA | 12 | $19 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 19 | $18.9 million | 0 | $0 |
| California Institute of Technology | Pasadena, CA | 11 | $18.8 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 28 | $17.9 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 16 | $17.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 24 | $17.6 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 27 | $17.4 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 17 | $17.4 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 12 | $16.6 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 23 | $16.6 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 30 | $16.1 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 26 | $15.6 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 23 | $15.1 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 18 | $14.6 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 11 | $14.6 million | 0 | $0 |
| Rockefeller University | New York, NY | 18 | $14.1 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 14 | $13.9 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 22 | $13.8 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 21 | $13.8 million | 0 | $0 |
| Clemson University | Clemson, SC | 6 | $13.7 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 19 | $13.2 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 12 | $13.2 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 14 | $13 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 20 | $12.8 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 11 | $12.6 million | 0 | $0 |
| Versiti Blood Health, Inc. | Milwaukee, WI | 9 | $11.8 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 13 | $11.4 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 15 | $11.3 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 7 | $11.2 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 11 | $10.8 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 11 | $10.7 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 15 | $10.7 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 3 | $10.6 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 27 | $10.5 million | 0 | $0 |
| Boise State University | Boise, ID | 4 | $10.4 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 14 | $10.3 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 19 | $45,340,395 | 0 | $0 |
| 2024 | 1,283 | $549,955,181 | 0 | $0 |
| 2023 | 2,125 | $871,986,762 | 0 | $0 |
| 2022 | 2,794 | $1,134,426,588 | 0 | $0 |
| 2021 | 3,279 | $1,398,819,531 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.